Literature DB >> 15543974

Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column.

Ziping Yang1, William S Hancock.   

Abstract

Glycosylation is one the most common post-translational modifications (PTM) and glycoproteins play fundamental roles in a diversity of biological processes. The development of an analytical approach to the study of variation of glycosylation patterns in serum samples has been hindered by the structural heterogeneity of this post-translational modification and the complexity of serum proteome. We have used the ability of different lectins to recognize specific glycosylation motifs to develop a specific affinity system that can achieve a comprehensive capture of serum glycoproteins. In a preliminary investigation, we evaluated the ability of five commonly used immobilized lectins to capture glycoproteins from human serum. SDS-PAGE analysis showed each lectin was able to enrich a subset of the serum glycoproteome and overlaps in lectin specificity were indeed observed. Based on these results and with the goal of studying the extent of the human serum glycoproteome, we then developed a multi-lectin affinity column containing Concanavalin A (Con A), Wheat germ and Jacalin lectin. The selection of lectins was also based on the known N-linked and O-linked glycan structures that are considered representative of the serum proteome. We then demonstrated that the capture of glycoproteins was specific, efficient and reproducible with this multi-lectin column. The results obtained with this affinity step indicated that about 10% of human serum proteins are glycosylated (weight/weight) and, after removal of six high abundance proteins, including albumin, at least 50% of the remaining proteins were glycosylated. We then evaluated the use of this affinity column to monitor changes in the pattern of glycosylation in serum samples by a controlled, stepwise release of the captured proteins from the multi-lectin affinity column with specific displacers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15543974

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  67 in total

1.  A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome.

Authors:  Zhi Zeng; Marina Hincapie; Sharon J Pitteri; Samir Hanash; Joost Schalkwijk; Jason M Hogan; Hong Wang; William S Hancock
Journal:  Anal Chem       Date:  2011-05-23       Impact factor: 6.986

2.  Proteomic screening of glycoproteins in human plasma for frailty biomarkers.

Authors:  Kinza S Shamsi; Anson Pierce; Aaron S Ashton; Dipti G Halade; Arlan Richardson; Sara E Espinoza
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

3.  Comparison of N-linked Glycoproteins in Human Whole Saliva, Parotid, Submandibular, and Sublingual Glandular Secretions Identified using Hydrazide Chemistry and Mass Spectrometry.

Authors:  Prasanna Ramachandran; Pinmanee Boontheung; Eric Pang; Weihong Yan; David T Wong; Joseph A Loo
Journal:  Clin Proteomics       Date:  2008-12       Impact factor: 3.988

Review 4.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

Review 5.  The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.

Authors:  Huiyuan Tang; Peter Hsueh; Doron Kletter; Marshall Bern; Brian Haab
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 6.  Global and site-specific analysis of protein glycosylation in complex biological systems with Mass Spectrometry.

Authors:  Haopeng Xiao; Fangxu Sun; Suttipong Suttapitugsakul; Ronghu Wu
Journal:  Mass Spectrom Rev       Date:  2019-01-03       Impact factor: 10.946

7.  Targeting deeper the human serum fucome by a liquid-phase multicolumn platform in combination with combinatorial peptide ligand libraries.

Authors:  Subhashini Selvaraju; Ziad El Rassi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-30       Impact factor: 3.205

8.  Automated platform for fractionation of human plasma glycoproteome in clinical proteomics.

Authors:  Majlinda Kullolli; William S Hancock; Marina Hincapie
Journal:  Anal Chem       Date:  2010-01-01       Impact factor: 6.986

9.  Targeting human serum fucome by an integrated liquid-phase multicolumn platform operating in "cascade" to facilitate comparative mass spectrometric analysis of disease-free and breast cancer sera.

Authors:  Subhashini Selvaraju; Ziad El Rassi
Journal:  Proteomics       Date:  2013-04-24       Impact factor: 3.984

10.  The development of an integrated platform to identify breast cancer glycoproteome changes in human serum.

Authors:  Zhi Zeng; Marina Hincapie; Brian B Haab; Samir Hanash; Sharon J Pitteri; Steven Kluck; Jason M Hogan; Jacob Kennedy; William S Hancock
Journal:  J Chromatogr A       Date:  2009-09-16       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.